Entrada Therapeutics (TRDA) Earnings Date & Reports
Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TRDA is expected to report earnings to rise 8.51% to -101 cents per share on May 07
Q1'26
Est.
$-1.02
Q4'25
Beat
by $0.04
Q3'25
Missed
by $0.07
Q2'25
Missed
by $0.22
Q1'25
Beat
by $0.31
The last earnings report on February 26 showed earnings per share of -93 cents, beating the estimate of -98 cents. With 134.09K shares outstanding, the current market capitalization sits at 519.52M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TRDA showed earnings on February 26, 2026. You can read more about the earnings report here.